戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 so target, Matrix metalloproteinase-7 (MMP-7/Matrilysin).
2 ursors by matrix metalloproteinase-7 (MMP-7; matrilysin).
3 r two MMPs, MMP-3 (stromelysin-1) and MMP-7 (matrilysin).
4 r epithelia in the prostate also overexpress matrilysin.
5 thus be exploited to yield metallohybrids of matrilysin.
6 es that are more similar to stromelysin than matrilysin.
7 arterectomy tissue in organ culture released matrilysin.
8 ith Leu in subsite P1' relative to wild type matrilysin.
9  MAT:A215V are similar to those of wild type matrilysin.
10 TIMP-1 inhibits re-epithelialization through matrilysin.
11 ctors enhance the activation and activity of matrilysin.
12 r pocket found in fibroblast collagenase and matrilysin.
13 ecific cleavage of the beta(4) integrin with matrilysin.
14                                              Matrilysin-1 (also called matrix metalloproteinase-7) is
15 -1 null mice and was correlated with reduced matrilysin-1 expression in BOA.
16 phospho-p38 and phospho-Erk1/2 kinases after matrilysin-1 expression.
17                     Forced expression of the matrilysin-1 gene in immortalized human normal airway ep
18 strate that there is increased expression of matrilysin-1 in human lesions and BOA in the CC10-human
19                             We conclude that matrilysin-1 may play an important role in the bronchiol
20 haete-scute homolog-1 mice were crossed with matrilysin-1 null mice and was correlated with reduced m
21                                 In addition, matrilysin-1 stimulated proliferation and inhibited Fas-
22 d HPLD1 cells, which do not normally express matrilysin-1, promoted cellular migration, suggesting a
23                                  Endometase (matrilysin 2 or MMP-26) is a putative early biomarker fo
24 trix metalloproteinase-26 (MMP-26/endometase/matrilysin-2) is a newly identified MMP and its structur
25 We previously reported that human endometase/matrilysin-2/matrix metalloproteinase (MMP) 26-mediated
26                             Human endometase/matrilysin-2/matrix metalloproteinase-26 (MMP-26) is a n
27 ve biochemical mechanism by which endometase/matrilysin-2/matrix metalloproteinase-26 (MMP-26) may pr
28                               We report that matrilysin, a matrix metalloproteinase, is constitutivel
29                                              Matrilysin, a matrix metalloproteinase, is expressed and
30 ions demonstrate that sulfated GAGs regulate matrilysin activation and its activity against specific
31 forms of chondroitin sulfate did not augment matrilysin activation or activity.
32 with matrix metalloproteinases and regulates matrilysin activity during airway epithelial repair.
33 ts airway re-epithelialization by inhibiting matrilysin activity, contributing to a stereotypic injur
34 itin-2,6-sulfate (CS-D) also did not enhance matrilysin activity, suggesting that the presentation of
35 identify E-cadherin as a novel substrate for matrilysin and indicate that shedding of E-cadherin ecto
36                                         Both matrilysin and macrophage metalloelastase were detected
37                               We report that matrilysin and macrophage metalloelastase, two broad-act
38 ificant increase in the expression levels of matrilysin and macrophage metalloelastase.
39 l lines differed from the HaCaT line in that matrilysin and TIMP-1 proteins were detected in conditio
40                            Similarly, MMP-7 (matrilysin) and MT1-MMP (membrane type 1 matrix metallop
41 rated by the action of the metalloproteinase matrilysin, and suggest that matrilysin cleavage of FasL
42                                              Matrilysin autolytically removes its N-terminal tripepti
43                                       Active matrilysin bound heparin (K(D), 150 nm) but less so to C
44 single tyrosine residue in the S1' pocket of matrilysin by leucine alters its P1' specificity to rese
45 ific product of myeloperoxidase, inactivates matrilysin by modifying adjacent tryptophan and glycine
46    We have shown that inactivation of MMP-7 (matrilysin) by HOCl coincides with the formation of a no
47  we report that the matrix metalloproteinase matrilysin can process recombinant and cell-associated F
48 three His ligands and the scaffolding of the matrilysin catalytic zinc site are different from that o
49 talloproteinase matrilysin, and suggest that matrilysin cleavage of FasL is an important mediator of
50                                    In vitro, matrilysin cleaved syndecan-1 from the surface of cells.
51                      Furthermore, TIMP-1 and matrilysin co-localized in airway epithelial cells adjac
52                     We found that TIMP-1 and matrilysin co-localized in the epithelium of human lungs
53                                     In vivo, matrilysin co-localized with E-cadherin at the basolater
54   In the involuting mouse prostate, FasL and matrilysin colocalized to the cell surface in a restrict
55                    In mouse small intestine, matrilysin colocalized with alpha-defensins (cryptdins)
56 ined to sites of macrophage-elastin contact, matrilysin confers macrophages with their most potent MM
57       Because elastolytically active MME and matrilysin consist only of a catalytic domain (CD), we s
58            These results indicate that while matrilysin contributes to the invasive phenotype, activa
59                  Because genetic ablation of matrilysin decreases tumor formation in multiple intesti
60                                              Matrilysin-deficient (MAT-/-) mice lacked mature cryptdi
61 sure of corneal wounds were observed between matrilysin-deficient and wild-type mice after wounding.
62 vascular endothelial growth factor (VEGF) in matrilysin-deficient and wild-type mouse corneas (experi
63                                              Matrilysin-deficient human macrophages fail to mediate a
64                                              Matrilysin-deficient mice (n = 17) and their age-matched
65 re the area of corneal neovascularization in matrilysin-deficient mice and wild-type littermates (exp
66 rences in corneal neovascularization between matrilysin-deficient mice and wild-type littermates seem
67 orneal epithelial cells were not elevated in matrilysin-deficient mice compared with the wild-type mi
68 ation after excimer laser keratectomy in the matrilysin-deficient mice measured 21.3% +/- 5.2% and 18
69            Corneal neovascularization in the matrilysin-deficient mice was confirmed by india ink pre
70    The area of corneal neovascularization in matrilysin-deficient mice was not significantly differen
71 nases, macrophage metalloelastase (MME), and matrilysin degrade insoluble elastin.
72              Biochemical studies showed that matrilysin degraded versican much more efficiently than
73               The properties of this form of matrilysin demonstrate that the propeptide is not essent
74                            Mice deficient in matrilysin demonstrated a 67% reduction in the apoptotic
75  Mmp7-/-, and Mmp10-/- mice identified 2,091 matrilysin-dependent and 1,628 stromelysin-2-dependent g
76                                        Human matrilysin devoid of its propeptide is expressed in Esch
77 ve precursors by matrix metalloproteinase-7 (matrilysin, EC, MMP-7(a)).
78                              Thus, to assess matrilysin effects on CD103-E-cadherin interactions in l
79                             Furthermore, all matrilysin-expressing benign intestinal tumors of the Mi
80              Mammary tissue from multiparous matrilysin-expressing mice showed decreased FasL express
81 basement membrane disruption was detected in matrilysin-expressing mice, which could account for the
82 factors secreted from monocytes could induce matrilysin expression in a human prostatic cell line.
83                                  We analyzed matrilysin expression in benign intestinal tumors from m
84 , flagellin-null mutants failed to stimulate matrilysin expression in cultured cells or in lungs infe
85 d physiologically relevant signal regulating matrilysin expression in epithelial cells.
86 e assessed if relevant CF pathogens regulate matrilysin expression in human lung epithelial cells.
87                                              Matrilysin expression in LNCaP cells was also induced by
88  specifically flagellin) potently stimulates matrilysin expression in lung epithelial cells and may m
89                                              Matrilysin expression increased apoptosis in the involut
90 a CF isolates and laboratory strains induced matrilysin expression to similar levels.
91                                              Matrilysin expression was increased in airway epithelial
92                                      Indeed, matrilysin expression was increased in migrating airway
93 tor released by P. aeruginosa that regulated matrilysin expression.
94 ascular proteoglycan was present at sites of matrilysin expression.
95 MPs with simple domain constituents, such as matrilysin, from the larger and more elaborate enzymes.
96              These observations suggest that matrilysin functions in injury-mediated responses of the
97                                        Thus, matrilysin functions in intestinal mucosal defense by re
98  tumors, leads to coordinate upregulation of matrilysin gene transcription, contributing to gastroint
99 cient to induce expression of the endogenous matrilysin gene.
100  and cell-associated FasL to sFasL, and that matrilysin-generated sFasL was effective at inducing apo
101 d expression of Bcl-2, Bcl-XL, survivin, and matrilysin, genes associated with a poor prognosis in ad
102 ence of kcat/K(m) for Dns-PLALWAR shows that matrilysin has a broad pH optimum (5.0-9.0) and the pKa
103 icity, the amino acids at these positions in matrilysin have been replaced by those found in stromely
104 siella pneumoniae) induced the expression of matrilysin in Calu-3 lung epithelial cells.
105 tochemistry revealed prominent expression of matrilysin in cells confined to the border between acell
106               The constitutive production of matrilysin in conducting airways, its upregulation after
107 otential mechanism for the overexpression of matrilysin in inflamed ducts and glands of the prostate.
108 e of this study was to determine the role of matrilysin in maintaining corneal avascularity during wo
109                       To address the role of matrilysin in Min intestinal tumorigenesis, we generated
110                      Bacteria did not induce matrilysin in other cell types, and expression of other
111 compared with wild-type animals, implicating matrilysin in this FasL-mediated process.
112 tivity of matrix metalloproteinase-7 (MMP-7, matrilysin) in vitro, suggesting that this oxidant activ
113 of stromelysin (HFS:L214Y/V215A) to resemble matrilysin increases activity (i.e., higher kcat/KM) tow
114 at loss of FasL is at least one mechanism of matrilysin-induced resistance to apoptosis.
115 ls coexpressing Fas and Fas ligand (FasL) to matrilysin induces apoptosis, whereas chronic exposure t
116                                          The matrilysin-inducing activity of THP-1 conditioned medium
117                  This is the first report of matrilysin induction by an inflammatory cytokine in a ce
118  use model peptides that mimic the region of matrilysin involved in this reaction, VVWGTA, VVWATA, an
119                             Glu-198 of human matrilysin is a conserved residue in the matrix metallop
120                                              Matrilysin is a matrix metalloprotease that is overexpre
121                                              Matrilysin is a matrix metalloproteinase expressed in th
122    Based on these findings, we conclude that matrilysin is a suppressor of the Min phenotype, possibl
123                    We showed previously that matrilysin is a target gene of beta-catenin-Tcf, the tra
124                  In normal adult human lung, matrilysin is expressed at low levels in the airway epit
125                                      Because matrilysin is produced in Paneth cells of the murine sma
126                                     Although matrilysin is required for closure of epithelial wounds
127 ave demonstrated that one MMP family member, matrilysin, is expressed in a high percentage of early-s
128  entactin with the matrix metalloproteinase, matrilysin, liberates peptides that retain E domain-medi
129 epithelial specific matrix metalloproteinase matrilysin (MAT) has been correlated with enhanced tumor
130                                              Matrilysin (MAT) prefers leucine over residues that have
131                       To examine the role of matrilysin (MAT), an epithelial cell-specific matrix met
132 elial transcriptional responses dependent on matrilysin (matrix metalloproteinase 7 [MMP-7]) and stro
133 erexpression of the matrix metalloproteinase matrilysin (matrix metalloproteinase-7) in the mouse mam
134                                              Matrilysin (matrix metalloproteinase-7) is expressed by
135                                              Matrilysin (matrix metalloproteinase-7) is highly expres
136                                              Matrilysin (matrix metallproteinase-7) is essential for
137                                              Matrilysin, matrix metalloproteinase (MMP)-7, is upregul
138                                              Matrilysin may play an important role in maintaining cor
139                        TIMP-1 also inhibited matrilysin-mediated cell migration and spreading in vitr
140                                        Thus, matrilysin-mediated shedding of syndecan-1/KC complexes
141                          We demonstrate that matrilysin mediates shedding of E-cadherin ectodomain fr
142 latinase (MMP 9), stromelysin 1 (MMP 3), and matrilysin (MMP 7) all processed this substrate efficien
143 A or B), stromelysins (MMP-3 and MMP-11), or matrilysin (MMP-7) affected SF/HGF-induced responses.
144                                No binding to matrilysin (MMP-7) and collagenase 1 (MMP-1) was detecte
145       Unlike the gelatinases (MMP-2 and -9), matrilysin (MMP-7) and collagenases (MMP-1 and -13) are
146 human matrix metalloproteinase (MMP) family, matrilysin (MMP-7) and gelatinase B/type IV collagenase
147                                              Matrilysin (MMP-7) expression is increased in lung injur
148 ate that HOCl inhibits the activity of human matrilysin (MMP-7) in vitro, suggesting that it might li
149                 The matrix metalloproteinase matrilysin (MMP-7) is expressed in the tumor cells of a
150 einases (MMPs) are tightly bound to tissues; matrilysin (MMP-7), although the smallest of the MMPs, i
151 ct of Brij-35 on human gelatinase B (MMP-9), matrilysin (MMP-7), and membrane-type 1 MMP (MT1-MMP) wa
152 pproach for rapid and sensitive detection of matrilysin (MMP-7, a biomarker involved in the degradati
153 lytically active matrix metalloproteinase 7 (matrilysin, MMP-7) and heparin-binding epidermal growth
154                                     In vivo, matrilysin (MMP7) activates pro-alpha-defensins (procryp
155                                    Increased matrilysin mRNA levels were detectable at 3 h post-infec
156                                           In matrilysin null mice, neutrophils remained confined in t
157  tissue, reepithelialization in trachea from matrilysin-null mice was essentially blocked.
158 -injured wild-type mice, but was not shed in matrilysin-null mice.
159 en in wild-type injured tissue was absent in matrilysin-null samples.
160 s C, values closely similar to those for the matrilysin produced by activation of the Chinese hamster
161 ia (Min) mice, we propose that regulation of matrilysin production by beta-catenin accumulation is a
162 -50-fold) and sustained (>24 h) induction of matrilysin production.
163 f factor, LEF-1, significantly downregulated matrilysin promoter activity, suggesting that beta-caten
164 iously observed coordinate regulation of the matrilysin promoter by beta-catenin and Ets family trans
165 gesting that beta-catenin transactivates the matrilysin promoter by virtue of its ability to abrogate
166 IL-1beta activates transcription through the matrilysin promoter in LNCaP cells.
167                                          The matrilysin promoter is upregulated as much as 12-fold by
168  transfection analyses with a chimeric human matrilysin promoter-chloramphenicol acetyltransferase re
169 nt to effect expression of luciferase from a matrilysin promoter-luciferase reporter plasmid.
170                              We propose that matrilysin promotes mammary tumor formation by enhancing
171                      We now demonstrate that matrilysin promotes resistance to apoptosis in vivo.
172 lysaccharide treatment substantially induced matrilysin protein and mRNA expression in LNCaP prostate
173                                       MMP-7 (matrilysin) rapidly cleaved TFPI to a major 35-kDa produ
174                               In conclusion, matrilysin regulates pulmonary localization of DC that e
175 lloelastase, stromelysin, collagenase-3, and matrilysin, respectively.
176                               The absence of matrilysin resulted in a reduction in mean tumor multipl
177  epithelial cells, transfection of activated matrilysin resulted in shedding of E-cadherin and accele
178 duces apoptosis, whereas chronic exposure to matrilysin selects for apoptosis-resistant cells.
179 helial cells have been repeatedly exposed to matrilysin, show a significant decrease in apoptosis.
180                    Our findings suggest that matrilysin, specifically expressed in atherosclerotic le
181 lation was found between mRNA expression for matrilysin, stromelysins 1-3, TIMP-1, or TIMP-3 and secr
182 ne products, a secreted phospholipase A2 and matrilysin, that has been implicated as modifiers of ade
183 omatrilysin and the activity of fully active matrilysin to cleave specific physiologic substrates.
184                 In murine intestinal tumors, matrilysin transcripts show striking overlap with the ac
185                                              Matrilysin was expressed by morphologically normal epith
186                                 Induction of matrilysin was mediated by a soluble, non-LPS bacterial
187                                              Matrilysin was not detected in germ-free mice, but the e
188                                              Matrilysin was present in lipid-laden macrophages, ident
189 ivation or while migrating over wounds, some matrilysin was released basally.
190 s and cell culture studies demonstrated that matrilysin was secreted lumenally by lung epithelium, bu
191 teady-state reaction of wild type and mutant matrilysin with substrates with Leu and Tyr residues in

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top